S-flurbiprofen Bioavailability Trial to Compare a Newly Developed Patch vs. a Marketed Tablet

NCT04505787 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Comparative Bioavailability

Interventions

DRUG: Esflurbiprofen hydrogel patch 165 mg (EFHP)
DRUG: Froben 100 mg comprimidos revestidos

Sponsor

SocraTec R&D GmbH

Collaborators

[object Object]
[object Object]